Trial Profile

A phase 1 multicenter, randomized, double-blind, placebo-controlled single dose, dose-ranging study of bivalent GI.1/GII.4 norovirus vaccine in healthy lactating females of at least 18 years of age and their breast-feeding infants (aged 30 days to 11 months)

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 17 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

15 Oct 2024 According to Vaxart media release, data from this trial will be presented at IDWeek 2024.
13 May 2024 According to a Vaxart media release, received support from the Bill & Melinda Gates Foundation.
30 Apr 2024 Topline analysis published in the Vaxart Media Release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com